Heart Disease Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trial Research
Study results from Macquarie University in the area of clinical trial research published
July 12th, 2009
"A novel antithrombotic agent, lumbrokinase, was evaluated in this pilot study for its efficacy in the treatment of symptomatic stable angina. This was a single-armed cohort study," researchers in Australia report. "The study was conducted at the National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia. The study comprised 10 patients who had coronary artery disease and stable angina and who consented to the trial. Patients were treated with oral lumbrokinase for 30 consecutive days in addition to their standard medical therapy. Stress technetium-99m sestamibi myocardial perfusion imaging (MPI) was performed before and at the conclusion of the active treatment...
Source: Heart Disease Weekly (2009-07-12)
|
